Literature DB >> 1994642

Prevalence of psammoma bodies in Papanicolaou-stained cervicovaginal smears.

S B Kern1.   

Abstract

Reports from sequential series of 234,318 cervicovaginal smears from a period of three years were reviewed to ascertain the prevalence and significance of psammoma bodies. Seven smears contained psammoma bodies. Three of the seven were associated with benign conditions and four were associated with a cancer (two serous papillary endometrial adenocarcinomas, one ovarian serous cystadenocarcinoma and one serous papillary carcinoma of the peritoneum). The prevalence of psammoma bodies in benign cases was much higher than reported in previous studies, in which most findings of psammoma bodies were associated with malignancy, particularly ovarian carcinoma. A consistent and useful feature in distinguishing psammoma bodies associated with benign or malignant disease was the presence of a few adherent small bland-appearing glandular cells in benign disorders and adherent malignant glandular cells in cases of carcinoma. A more conservative work-up may be merited in young women with clearly benign cells associated with psamoma bodies in a cervicovaginal smear and an otherwise negative physical examination and noncontributory endometrial sampling.

Entities:  

Mesh:

Year:  1991        PMID: 1994642

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  3 in total

1.  Psammoma bodies on routine cervical smear.

Authors:  D A Gould; S A Butler-Manuel; P G Carter; M P Young; D P Barton
Journal:  J R Soc Med       Date:  1998-07       Impact factor: 5.344

2.  Repurposing the Pap smear: one step closer to gynecologic cancer screening.

Authors:  Shannon N Westin; Gordon B Mills; Andrea P Myers
Journal:  Sci Transl Med       Date:  2013-01-09       Impact factor: 17.956

3.  Prevalence and significance of psammoma bodies in cervicovaginal smears in a cervical cancer screening program with emphasis on a case of primary bilateral ovarian psammocarcinoma.

Authors:  Teresa Pusiol; Anna M Parolari; Irene Piscioli; Luca Morelli; Franca Del Nonno; Stefano Licci
Journal:  Cytojournal       Date:  2008-04-16       Impact factor: 2.091

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.